Amy Peng

3.4k total citations · 2 hit papers
28 papers, 2.5k citations indexed

About

Amy Peng is a scholar working on Atomic and Molecular Physics, and Optics, Artificial Intelligence and Epidemiology. According to data from OpenAlex, Amy Peng has authored 28 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Atomic and Molecular Physics, and Optics, 8 papers in Artificial Intelligence and 6 papers in Epidemiology. Recurrent topics in Amy Peng's work include Quantum Information and Cryptography (8 papers), Quantum optics and atomic interactions (6 papers) and Influenza Virus Research Studies (5 papers). Amy Peng is often cited by papers focused on Quantum Information and Cryptography (8 papers), Quantum optics and atomic interactions (6 papers) and Influenza Virus Research Studies (5 papers). Amy Peng collaborates with scholars based in United States, Australia and Canada. Amy Peng's co-authors include Jonathon Gillen, Markus Greiner, Simon Fölling, Waseem Bakr, Jonathan Simon, M. Eric Tai, Ruichao Ma, Lode Pollet, Frederick G. Hayden and David P. Calfee and has published in prestigious journals such as Nature, Science and Physical Review Letters.

In The Last Decade

Amy Peng

26 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A quantum gas microscope for detecting single atoms in a Hubbard-regime optical lattice

2009 1.0k citations Waseem Bakr, Jonathon Gillen et al. Nature profile →
Probing the Superfluid–to–Mott Insulator Transition at the Single-Atom Level

2010 558 citations Waseem Bakr, Amy Peng et al. Science profile →

Peers

Countries citing papers authored by Amy Peng

Since Specialization

Citations

This map shows the geographic impact of Amy Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Peng more than expected).

Fields of papers citing papers by Amy Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Peng. The network helps show where Amy Peng may publish in the future.

Co-authorship network of co-authors of Amy Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Peng. A scholar is included among the top collaborators of Amy Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Peng. Amy Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV- 2 infection in Ontario, Canada 2025 ·BMC Infectious Diseases ·(unknown), Amy Peng, Ashleigh R. Tuite, (unknown), David N. Fisman	0
2	Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex 2024 ·PNAS Nexus ·Amy Peng, (unknown), (unknown), Ashleigh R. Tuite, David N. Fisman	1
3	Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic 2023 ·Canada Communicable Disease Report ·Amy Peng, (unknown), (unknown), Ashleigh R. Tuite, David N. Fisman	6
4	Differential Motion Dynamics of Synaptic Vesicles Undergoing Spontaneous and Activity-Evoked Endocytosis 2012 ·Neuron ·Amy Peng, Ziv Rotman, Pan‐Yue Deng, Vitaly A. Klyachko	51
5	Probing the Superfluid–to–Mott Insulator Transition at the Single-Atom Level breakdown → 2010 ·Science ·Waseem Bakr, Amy Peng, M. Eric Tai, Ruichao Ma, Jonathan Simon, Jonathon Gillen, Simon Fölling, Lode Pollet, Markus Greiner	558
6	Quantum gas microscope 2009 ·Bulletin of the American Physical Society ·Jonathon Gillen, Waseem Bakr, Amy Peng, (unknown), Markus Greiner	1
7	A quantum gas microscope for detecting single atoms in a Hubbard-regime optical lattice breakdown → 2009 ·Nature ·Waseem Bakr, Jonathon Gillen, Amy Peng, Simon Fölling, Markus Greiner	1001
8	Effect of atomic noise on optical squeezing via polarization self-rotation in a thermal vapor cell 2006 ·Physical Review A ·Magnus T. L. Hsu, G. Hétet, Amy Peng, C. C. Harb, Hans‐A. Bachor, Mattias Johnsson, J. J. Hope, Ping Koy Lam, Aurélien Dantan, J. Cviklinski, Alberto Bramati, M. Pinard	23
9	Squeezing and entanglement delay using slow light 2005 ·Physical Review A ·Amy Peng, Mattias Johnsson, Warwick P. Bowen, Ping Koy Lam, Hans‐A. Bachor, J. J. Hope	57
10	Unconditional Preparation of Entanglement between Atoms in Cascaded Optical Cavities 2003 ·Physical Review Letters ·(unknown), Amy Peng, Mile Gu, A. S. Parkins	131
11	Motion-light parametric amplifier and entanglement distributor 2002 ·Physical Review A ·Amy Peng, A. S. Parkins	19
12	A Population Pharmacokinetic Analysis of Zanamivir in Subjects with Experimental and Naturally Occurring Influenza: Effects of Formulation and Route of Administration 2000 ·The Journal of Clinical Pharmacology ·Amy Peng, Elizabeth K. Hussey, Katy H. P. Moore	16
13	Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis 2000 ·Genes Chromosomes and Cancer ·(unknown), Richard Desper, Christos H. Papadimitriou, Amy Peng, David S. Alberts, Raymond Taetle, Jeffrey M. Trent, (unknown)	43
14	Direct Measurement of the Anti-Influenza Agent Zanamivir in the Respiratory Tract following Inhalation 2000 ·Antimicrobial Agents and Chemotherapy ·Amy Peng, Stefano Milleri, Daniel S. Stein	51
15	Nasal Cytokine and Chemokine Responses in Experimental Influenza A Virus Infection: Results of a Placebo‐Controlled Trial of Intravenous Zanamivir Treatment 1999 ·The Journal of Infectious Diseases ·Richard Fritz, Frederick G. Hayden, David P. Calfee, Lindsey Cass, Amy Peng, W. Gregory Alvord, Warren Strober, Stephen E. Straus	170
16	Safety and Efficacy of Once Daily Intranasal Zanamivir in Preventing Experimental Human Influenza a Infection 1999 ·Antiviral Therapy ·David P. Calfee, Amy Peng, Elizabeth K. Hussey, Monica Lobo, Frederick G. Hayden	34
17	Initial clinical experience with remifentanil, a new opioid metabolized by esterases 1997 ·Journal of Clinical Anesthesia ·Mark Dershwitz, Gail I. Randel, Carl E. Rosow, Robert J. Fragen, Patricia M. Connors, (unknown), D.L. Shaw, Amy Peng, Brenda D. Jamerson	85
18	Initial Clinical Experience with Remifentanil, a New Opioid Metabolized by Esterases 1995 ·Anesthesia & Analgesia ·Mark Dershwitz, Gail I. Randel, Carl E. Rosow, Robert J. Fragen, Patricia M. Connors, (unknown), (unknown), Amy Peng, Brenda D. Jamerson	36
19	Initial Clinical Experience with Remifentanil, a New Opioid Metabolized by Esterases 1995 ·Anesthesia & Analgesia ·Mark Dershwitz, Gail I. Randel, Carl E. Rosow, Robert J. Fragen, Patricia M. Connors, (unknown), (unknown), Amy Peng, Brenda D. Jamerson	3
20	Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women 1994 ·The American Journal of Medicine ·H. Mitchell Perry, Wayne Hall, (unknown), David W. Bartels, John B. Kostis, Raymond R. Townsend, (unknown), Amy Peng, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact